
Why Hims & Hers Crash-Landing Sparks Debate: Is the Margin of Safety Still Intact?
HIMS: Riding the Wave of Personalized Healthcare Amidst GLP-1 Therapies Health Insight Medical Solutions, or HIMS, has been making headlines lately with its steep correction in the stock market. This correction comes as no surprise, given the expensive valuations and the headwinds from the now available FDA-approved GLP-1 therapies. But let’s delve deeper into this…